Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 10_1_18.1
Adverse events in patients receiving hip joint replacement due to degenerative conditions, United States, 2004 and 2006a
Population group 2006 2004
Exposed Adverse events Percent SE Exposed Adverse events Percent SE
Total * * * * 306 15 4.90 1.23
Age Under 65 * * * * * * * *
65–74 * * * * * * * *
75 and over * * * * 157 14 8.92 2.27
Gender Male * * * * * * * *
Female * * * * * * * *
Race White * * * * 286 15 5.24 1.32
Other * * * * * * * *
Diabetes Yes * * * * * * * *
No * * * * 261 12 4.60 1.30
Obesity Yes * * * * * * * *
No * * * * 275 14 5.09 1.33
Cerebrovascular disease Yes * * * * * * * *
No * * * * 276 14 5.07 1.32
CHF/pulmonary edema Yes * * * * * * * *
No * * * * 283 14 4.95 1.29
COPD Yes * * * * * * * *
No * * * * * * * *
Smoking Yes * * * * * * * *
No * * * * 280 13 4.64 1.26
Cancer No DNA DNA DNA DNA 253 12 4.74 1.34
Yes DNA DNA DNA DNA * * * *
Corticosteroids Yes * * * * * * * *
No * * * * 296 14 4.73 1.23
Coronary artery disease Yes * * * * * * * *
No * * * * 239 11 4.60 1.36
Renal disease Yes * * * * * * * *
No * * * * 292 13 4.45 1.21

a Data include Medicare beneficiaries discharged from January to December.

DNA - Data have not been analyzed.

* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 

AHRQ Advancing Excellence in Health Care